Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BioMomentum Advisors ApS
APS
Active
CVR 44694670
Marguerite Vibys Plads 6, 6. tv
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2024
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 257K
+31% vs 2024
EBITDA margin
22.1%
+23% vs 2024
Equity ratio
48.2%
Financial strength
Net profit 2025
DKK 43K
+27% vs 2024
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
DKK 257K
+31%
EBITDA
DKK 57K
+23%
Net profit
DKK 43K
+27%
Total assets
DKK 243K
+65%
Equity
DKK 117K
+58%
Employees
1
—
Company information
Legal name
BioMomentum Advisors ApS
CVR number
44694670
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
1. marts 2024
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Contact
Address
Marguerite Vibys Plads 6, 6. tv
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Frederiksberg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
DKK thousands
Item
2024
2025
Revenue
196
257
Staff expenses
-150
-200
EBITDA
46
57
Depreciation & amort.
-0
-0
EBIT
46
57
Net financials
-1
-0
Profit before tax
45
57
Tax
11
13
Net profit
34
43
Balance sheet
DKK thousands
Item
2024
2025
Total assets
147
243
Equity
74
117
Long-term debt
0
0
Short-term debt
73
126
Total debt
73
126
Financial ratios
5-year trend
EBITDA margin
22.1%
This company
15.8%
Market median
+40% vs market
2024
2025
Equity ratio
48.2%
This company
38.2%
Market median
+26% vs market
2024
2025
Return on equity
36.8%
This company
18.4%
Market median
+100% vs market
2024
2025
Net profit margin
16.8%
This company
8.1%
Market median
+107% vs market
2024
2025
Asset turnover
1.06×
This company
1.12×
Market median
+5% vs market
2024
2025
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-11-01 – 2025-10-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-03-01 – 2024-10-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
GD
Giles Dudley
Management
Management
2024
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Church Street ApS
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Church Street ApS
BioMomentum Advisors ApS
(this company)
Board network connections
Board members of BioMomentum Advisors ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Giles Dudley
Management
0 companies